BridgeBio Pharma, Inc. (BBIO)
77.15
-0.55
(-0.71%)
USD |
NASDAQ |
Apr 16, 14:51
BridgeBio Pharma Research and Development Expense (Quarterly) : 116.42M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 3.133B |
| Mirum Pharmaceuticals, Inc. | 51.03M |
| Insmed, Inc. | 254.91M |
| Eli Lilly & Co. | 3.802B |
| Vanda Pharmaceuticals, Inc. | 29.01M |